ESC 365 - Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

ESC Premium Access

Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Session: Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Topic: Diabetes and the Heart

Speaker: Professor S. Jacob (Villingen, DE) Professor N. Marx (Aachen, DE) Professor F. Cosentino (Stockholm, SE) Professor J. Deanfield (London, GB)

Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speakers

Professor Stephan Jacob

Villingen (Germany)

8 presentations

0 follower

Professor Nikolaus Marx

RWTH University Hospital Aachen, Aachen (Germany)

52 presentations

13 followers

Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)

26 presentations

1 follower

Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

53 presentations

3 followers

2 more presentations in this session

Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Speaker: Professor F. Cosentino (Stockholm, SE)

Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?

Speaker: Professor N. Marx (Aachen, DE)

Access the full session

Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Speakers: Professor S. Jacob, Professor N. Marx, Professor F. Cosentino, Professor J. Deanfield, Professor F. Cosentino...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources